drugset / Trial / NCT01255358

Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients

NCT01255358 ↗

Phase 2 Completed 22 enrolled Quince Therapeutics S.p.A.
NaSingle-groupOpen-labelTreatment

Summary

The study has the aim to evaluate the improvement in CNS symptoms measured by International Co-operative Ataxia Rating Scale (ICARS) in patients with ataxia teleangectasia (AT), during a period of treatment with ERY-DEX (dexamethasone sodium phosphate ex vivo encapsulated into human autologous erythrocytes).

Timeline

Start
2011-02
Primary completion
2011-09
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule — —